The discovery of a relationship between Zn transporter gene variants and T2D led to the hypothesis that Zn intake may affect insulin and/or glucose metabolism [51], thus making SLC30A8 polymorphisms good candidates to modify Zn requirements. The gene discussed is SLC30A8; the disease is type 2 diabetes mellitus.